Table 1.
Microvessel diameter (μm), centerline red blood cell velocity (μm s−1) and volumetric blood flow (pl s−1) of endometrial grafts after autologous transplantation into the dorsal skinfold chambers of hormonally synchronized Syrian golden hamsters, which were treated daily with rapamycin or vehicle (control)
Day 2 | Day 4 | Day 7 | Day 10 | Day 14 | |
---|---|---|---|---|---|
Microvessel diameter (μm) | |||||
Rapamycin | 16.8±1.0 | 15.3±0.4a | 14.1±0.4a* | 13.9±0.8a* | 13.1±0.4a* |
Control | 16.2±1.0 | 14.8±0.7 | 11.7±0.3b | 11.5±0.4b | 11.3±0.2b |
Centerline red blood cell velocity (μm s−1) | |||||
Rapamycin | 46.4±18.9 | 95.3±10.1 | 172.8±16.4b | 238.7±22.8c | 215.6±28.3b |
Control | 17.7±2.4 | 117.9±28.2a | 190.8±14.4a | 179.0±19.9a | 181.7±19.0a |
Volumetric blood flow (pl s−1) | |||||
Rapamycin | 6.5±2.0 | 12.8±1.5a | 21.3±2.2b | 27.9±5.5b | 22.2±1.9b* |
Control | 3.0±0.6 | 14.7±3.0a | 15.6±1.3a | 14.7±2.6a | 14.2±1.6a |
Means±s.e.m.
P<0.05 vs day 2 within each individual group;
P<0.05 vs day 2 and 4 within each individual group;
P<0.05 vs day 2, 4 and 7 within each individual group;
P<0.05 vs control animals at corresponding time points.